S.Korea's SK Bioscience in deal with AstraZeneca on vaccine

SK Chemicals

21/07/2020 09:11

SEOUL, July 21 (Reuters) - SK Bioscience  285130.KS  has
signed a letter of intent with Britain's AstraZeneca  AZN.L  for
global production of its experimental COVID-19 vaccine, the
South Korean company said on Tuesday. 
    South Korea's health ministry will also participate in the
cooperation, the company said in a statement.

 (Reporting by Sangmi Cha; editing by Jason Neely)
 ((Sangmi.Cha@thomsonreuters.com; +82 2 3704 5646; Reuters
Messaging: sangmi.cha.thomsonreuters.com@reuters.net))